Which agents are used in hydration therapy to prevent contrast-induced nephropathy (CIN)?
https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly93d3cuc3RhZ2luZy5tZWRzY2FwZS5jb20vYW5zd2Vycy8yNDY3NTEtNzc3Mzcvd2hpY2gtYWdlbnRzLWFyZS11c2VkLWluLWh5ZHJhdGlvbi10aGVyYXB5LXRvLXByZXZlbnQtY29udHJhc3QtaW5kdWNlZC1uZXBocm9wYXRoeS1jaW4=
Hydration therapy, typically with intravenous saline, is the cornerstone of contrast-induced nephropathy (CIN) prevention. However, other agents have have demonstrated some benefit in prevention of CIN, including N-acetylcysteine (NAC) and statins.